Tatsuo Kagimura
Overview
Explore the profile of Tatsuo Kagimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
658
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishi H, Nangaku M, Sofue T, Kagimura T, Narita I
ESC Heart Fail
. 2024 Dec;
PMID: 39696837
Aims: Blood levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the...
2.
Wada S, Koga M, Kagimura T, Toyoda K, Nagai Y, Aoki S, et al.
J Neurol Sci
. 2024 Dec;
468():123342.
PMID: 39673820
Background And Aims: We aimed to investigate long-term changes in carotid intima-media thickness (IMT) based on baseline blood pressure (BP) levels in non-cardioembolic stroke patients. Methods: Patients aged 45-80 years...
3.
Hasegawa T, Murata S, Kagimura T, Omae K, Tanaka A, Takahashi K, et al.
Clocks Sleep
. 2024 Nov;
6(4):668-681.
PMID: 39584974
In this study, we investigated the sleep-wake rhythm of nursery school children with the aim of supporting their health and mental/physical development. We analyzed 4881 children from infancy to 6...
4.
Sakai C, Sakai N, Peterson C, Ohta T, Oishi H, Fujinaka T, et al.
Interv Neuroradiol
. 2024 Aug;
:15910199241262851.
PMID: 39109531
Background: Neuroendovascular procedures, especially those involving significant vessel tortuosity, giant intracranial aneurysms, or distally located lesions, frequently necessitate exchange methods. However, exchange maneuvers pose a risk of inadvertent vessel injury....
5.
Nakagawa S, Kowa H, Takagi Y, Kakei Y, Kagimura T, Sanada S, et al.
Contemp Clin Trials Commun
. 2024 Jul;
40:101326.
PMID: 39021673
Aim: This study aimed to evaluate the efficacy of a non-pharmaceutical multimodal intervention program consisting of physical exercise, cognitive stimulation, and health education in a group setting to slow the...
6.
Nakai K, Nishino T, Kagimura T, Narita I
J Nephrol
. 2024 Jun;
37(8):2327-2335.
PMID: 38941000
Background: Although the widespread use of long-acting erythropoiesis-stimulating agents (ESAs) has facilitated the improvement of anemia in patients with chronic kidney disease (CKD), the improvement in prognosis has not been...
7.
Gohda T, Murakoshi M, Suzuki Y, Kagimura T, Wada T, Narita I
Diabetes Res Clin Pract
. 2024 Apr;
212:111682.
PMID: 38677368
Aims: It is unclear whether the effect of proteinuria on rapid kidney function decline is equivalent among diabetic kidney disease (DKD), non-DKD with diabetes (NDKD+DM), and nephrosclerosis without diabetes (NS-DM),...
8.
Kato M, Ito H, Yamakawa A, Kagimura T, Fukagawa M, Yamamoto M, et al.
Ther Apher Dial
. 2024 Mar;
28(4):580-590.
PMID: 38471797
Introduction: The clinical benefits of aspirin in patients undergoing hemodialysis remain unclear. Methods: The secondary analysis of the LANDMARK trial investigated whether aspirin use was associated with cardiovascular events (CVEs)...
9.
Tooth Loss as a Predictor of Long-Term Care Requirements in the Elderly: A Study in Kobe City, Japan
Kakei Y, Kagimura T, Yamamoto Y, Osaki T, Kajita H, Kojima S, et al.
Cureus
. 2023 Dec;
15(12):e49851.
PMID: 38050582
Introduction: The Kobe project, which utilizes prospective data from the national health insurance system, focuses on early detection and preventive strategies through the Frail Kenshin health check-up program. Previous research...
10.
Saito S, Suzuki K, Ohtani R, Maki T, Kowa H, Tachibana H, et al.
JAMA Netw Open
. 2023 Dec;
6(12):e2344938.
PMID: 38048134
Importance: Recent evidence indicates the efficacy of β-amyloid immunotherapy for the treatment of Alzheimer disease, highlighting the need to promote β-amyloid removal from the brain. Cilostazol, a selective type 3...